Time to rethink extended thromboprophylaxis after cancer surgery?

J Thromb Haemost. 2023 Feb;21(2):198-199. doi: 10.1016/j.jtha.2022.11.015.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Enoxaparin
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / surgery
  • Postoperative Complications / drug therapy
  • Postoperative Complications / prevention & control
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / etiology
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants
  • Enoxaparin
  • Heparin, Low-Molecular-Weight